A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.
This healthcare technology firm, focused on Medicare Advantage plans, reported a notable insider sale amid muted stock performance.
Overview
On May 18, 2026, Board of Directors member Dr. Carladenise Armbrister Edwards reported a direct sale of 67,160 shares of Clover Health Investments (NASDAQ:CLOV) in an open-market transaction, according to the SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average reported price ($3.42); post-transaction value based on May 18, 2026 closing price.
Details
* 1-year price change calculated using May 18, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.